Market Research Insight

The Infusion Pump Market is expanding rapidly due to the rise in chronic diseases, technological advancements, and increasing demand for home healthcare. North America leads, with significant growth in Asia-Pacific driven by improving healthcare infrastructure. #InfusionPump #InfusionPumpmarket

The Cell Culture Market is expanding rapidly due to advancements in biopharmaceutical production, increased research in cancer and stem cell studies, and the rising demand for regenerative medicine. North America leads, with significant growth in Asia-Pacific. #CellCultureMarket #CellCulture

The Lateral Flow Assays Market is growing swiftly, driven by increased demand for rapid diagnostics, advancements in technology, and the rise in infectious diseases. North America leads, with significant growth in the Asia-Pacific region. #LateralFlowAssaysMarket #LateralFlowAssays

Global 𝐅𝐥𝐨𝐰 𝐂𝐲𝐭𝐨𝐦𝐞𝐭𝐫𝐲 market worth to Reach $7.0 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐚𝐭 https://lnkd.in/gYC-uQxT The size of global flow cytometry market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: BD Danaher Corporation Thermo Fisher Scientific Agilent Technologies Sony Biotechnology Inc. (SUBSIDIARY OF SONY) Bio-Rad Laboratories Miltenyi Biotec Enzo Biochem Inc Sysmex Corporation bioMérieux Cytonome Sartorius Cytek Biosciences Union Biometrica, Inc. Luminex (A DIASORIN COMPANY) Apogee Flow Systems LTD. Stratedigm, Inc. NanoCellect Biomedical, Inc. On-chip Biotechnologies (USA) NEXCELOM BIOSCIENCE LTD. BennuBio, Inc. ORFLO Technologies Bay Biosciences LLC. CytoBuoy B.V. BioLegend #flowcytometrymarket #flowcytometry

The global 𝐦𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜𝐬 market in terms of revenue was estimated to be worth $22.3 billion in 2023 and is poised to reach $41.1 billion by 2028, growing at a CAGR of 13.0% from 2023 to 2028. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐚𝐭 https://lnkd.in/duBsXUka 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Thermo Fisher Scientific PerkinElmer Becton, Dickinson and Company (BD) Agilent Technologies Bio-Rad Laboratories F. Hoffmann-La Roche Ltd (ROCHE) Danaher Corporation Illumina Fluidigm Sciences, Inc. (FLUIDIGM) Abbott (ABBOTT) bioMérieux Hologic, Inc. Quidel (QUIDEL) SMC Parker Hannifin (PARKER-HANNIFIN) IDEX Corporation Fortive (FORTIVE) Aignep SPA Dolomite Microfluidics (DOLOMITE MICROFLUIDICS) Elveflow Microfluidics | an Elvesys brand uFluidix NanoString Technologies, Inc. Nortis Farmaceutica INC. Innovative Biochips, LLC Fluidic Analytics #Microfluidics

Cannabis Testing Market to Reach $4.0 billion by 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐚𝐭 https://lnkd.in/gMt3gS4x The global cannabis testing market in terms of revenue was estimated to be worth $1.8 billion in 2024 and is poised to reach $4.0 billion by 2029, growing at a CAGR of 17.2% from 2024 to 2029. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: SHIMADZU CORPORATION Agilent Technologies Danaher Corporation Thermo Fisher Scientific India SGS (Société Générale de Surveillance) Merck Restek Corporation PerkinElmer Hamilton Company Sigma Analytical Services SC Labs AZ PHARMLABS LLC ProVerde Laboratories Eurofins Scientific Finland Oy Green Leaf Lab Kaycha Group Holdings LLC Accelerated Technology Laboratories, Inc. CloudLIMS LabWare LabLynx, Inc. (LabLynx LIMS) ENCORE LABS Trichome Analytical | Cannabis Testing Laboratory Green Scientific Labs Digipath, Inc. (DPL Nevada LLC) #CannabisTesting

Unlocking Potential: Exploring the Active Pharmaceutical Ingredient Market 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐚𝐭 https://lnkd.in/gyGuVfZ6 The size of global active pharmaceutical ingredient market in terms of revenue was estimated to be worth $163.5 billion in 2024 and is poised to reach $238.3 billion by 2029, growing at a CAGR of 7.8% from 2024 to 2029. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Pfizer Teva Pharmaceuticals GSK Sanofi Viatris Divi's Laboratories Limited GROUPEMENT AGRICOLE D'EXPLOITATION EN COMMUN RECONNU DES GRANDES PLANCHES-SANDOZ Boehringer Ingelheim International SK Pharma Eli Lilly and Company Merck AbbVie F. Hoffmann-La Roche Ltd AstraZeneca Dr. Reddy's Laboratories Ranbaxy Cipla AUROBINDO PHARMA LTD Evonik Industries AG Procurement Building Hikma Pharmaceuticals BASF Alembic Pharmaceuticals Limited Aburaihan Pharmaceutical Co. Curia Global Cambrex API PHARMA TECH Sreepathi Pharmaceuticals Limited - India SHILPA MEDICARE LTD Nanjing Jianyou Biochemical Pharmaceutical Hovione Chemcon Speciality Chemicals Limited Pharco Corporation #ActivePharmaceuticalIngredient

The Recombinant Proteins Market is growing rapidly, driven by advancements in biotechnology, increasing therapeutic applications, and rising research activities. Demand is fueled by biopharmaceutical production, diagnostics, and global expansion into emerging markets. #RecombinantProteins #RecombinantProteinsmarket

The global mass spectrometry market is expanding rapidly, driven by advancements in technology and increased demand in pharmaceuticals and biotechnology. It's expected to grow significantly, reflecting its vital role in scientific research and diagnostics. #massspectrometry #massspectrometrymarket

The size of global 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 market in terms of revenue was estimated to be worth USD 48.5 billion in 2024 and is poised to reach USD 71.1 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐚𝐭 https://lnkd.in/dqfhkcvp 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Medtronic Abbott Dexcom Dexcom Nederland GE HealthCare Philips Nihon Kohden America Mindray Animal Medical INTERNATIONAL LTD. Mindray Animal Medical North America Edwards Lifesciences CORPORATION Getinge Baxter International Inc. Dragerwerk Verwaltungs AG & CO. Boston Scientific Masimo Omron Automation Archimedes SAS (Natus Medical Incorporated) Compumedics Limited - Official Nonin Medical, Inc. #patientmonitoringDevices